Elekta (OTCMKTS:EKTAY) Shares Gap Up – Should You Buy?

Elekta AB (OTCMKTS:EKTAY)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $4.88, but opened at $5.24. Elekta shares last traded at $5.13, with a volume of 684 shares traded.

Analysts Set New Price Targets

Separately, Danske downgraded Elekta to a “hold” rating in a report on Tuesday, June 3rd.

Elekta Trading Up 2.9%

The company has a quick ratio of 0.86, a current ratio of 1.09 and a debt-to-equity ratio of 0.70. The company’s fifty day moving average price is $5.10 and its two-hundred day moving average price is $5.39. The firm has a market cap of $1.97 billion, a PE ratio of 102.50 and a beta of 1.22.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Wednesday, May 28th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.02). Elekta had a return on equity of 11.55% and a net margin of 1.15%. The company had revenue of $503.22 million for the quarter, compared to analysts’ expectations of $507.19 million. As a group, sell-side analysts forecast that Elekta AB will post 0.36 earnings per share for the current fiscal year.

About Elekta

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.